skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

The route to diabetes: Loss of complexity in the glycemic profile from health through the metabolic syndrome to type 2 diabetes

Original Research

(3483) Views  (1178) Full article downloads

Authors: Juan Churruca, Luis Vigil, Esther Luna, Julian Ruiz-Galiana, Manuel Varela

Published Date August 2008 Volume 2008:1 Pages 3 - 11
DOI: http://dx.doi.org/10.2147/DMSO.S3812

Juan Churruca, Luis Vigil, Esther Luna, Julian Ruiz-Galiana, Manuel Varela

Servicio de Medicina Interna, Hospital de Móstoles, Mostoles, Madrid, Spain

Aims: In many physiologic systems, the evolution from health to disease correlates with a loss of complexity in the system’s output. We analyze the difference in complexity of the glycemic profile in healthy volunteers (H), patients with the metabolic syndrome (MS), and patients with type 2 diabetes mellitus (DM).

Methods: We measured interstitial fluid glucose every 5 minutes for 3 days in 10 H, 10 MS, and 10 DM. Complexity of the glycemic profile was evaluated by means of detrended fluctuation analysis (DFA). Mean amplitude of glycemic excursions (MAGE) was also calculated.

Results: Glucose profile was more complex (lower DFA) in healthy subjects than in patients with MS or DM (mean DFA [SD]: H: 1.25 (0.10), MS: 1.39 (0.07), DM: 1.42 (0.10). ANOVA: F2,27 = 9.94, p = 0.001). DM had also a less complex profile than MS, but this difference was not statistically significant. There was an inverse relation between complexity (lower DFA) and the number of MS defining criteria (rho = 0.55, p = 0.002) and between complexity and MAGE (r = 0.68, p < 0.0001).

Conclusions: There is a progressive loss of complexity in the glycemic profile from health, through the metabolic syndrome to type 2 diabetes mellitus. This loss of complexity precedes hyperglycemia and correlates with other markers of disease progression. Complexity analysis may be a useful tool to track the evolution from health to type 2 diabetes. Furthermore, it may provide a way to measure glycemic control in real-life situations and has some distinct advantages over other conventional variability metrics.

Keywords: complexity, metabolic syndrome, type 2 diabetes mellitus, detrended fluctuation analysis, glycemic profile








Readers of this article also read:

Assessing the effect of weight and weight loss in obese persons with type 2 diabetes
Adipose inflammation: cause or consequence of obesity-related insulin resistance
Ego mechanisms of defense are associated with patients’ preference of treatment modality independent of psychological distress in end-stage renal disease
Can a gentamicin-specific chart reduce neonatal medication errors?
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
Dashboards in neonatology
Obesity and the development of type 2 diabetes: the effects of fatty tissue inflammation
Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach
Management of diabetes across the course of disease: minimizing obesity-associated complications
Obesity: considerations about etiology, metabolism, and the use of experimental models
  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio